AbbVie to Host Second-Quarter 2024 Earnings Conference Call
AbbVie (NYSE: ABBV) is set to release its second-quarter 2024 financial results on Thursday, July 25, 2024, before the market opens.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AbbVie (NYSE: ABBV) is set to release its second-quarter 2024 financial results on Thursday, July 25, 2024, before the market opens. The company will hold a live webcast of the earnings conference call at 8 a.m. Central time, accessible through its Investor Relations website. Additionally, an archived edition of the session will be made available later the same day.
Details
News Market Reaction – ABBV
The recorded move for ABBV in the trading session of this news was -2.59%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-host-second-quarter-2024-earnings-conference-call-302184875.html
SOURCE AbbVie
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.